Trazodone vs. Quviviq

See how Trazodone and Quviviq compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Trazodone is FDA-approved only for major depressive disorder, so using it for insomnia is an off-label practice not reviewed by the FDA for that purpose.

  • Quviviq (daridorexant) is a dual orexin receptor antagonist specifically FDA-approved for insomnia in adults, with its own controlled-substance and hepatic dosing rules.

  • Generic trazodone costs far less per month than Quviviq, but Quviviq's label includes clinical trial data on sleep onset and maintenance that trazodone's label does not.

Trazodone vs. Quviviq Drug Summary

Trazodone

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) antidepressant that the FDA approved for major depressive disorder in adults. It is not FDA-approved for insomnia, but it is widely prescribed off-label at lower bedtime doses to help people fall and stay asleep. For depression it is taken multiple times a day in divided doses; for sleep it is typically taken once at night.

Quviviq

Quviviq (daridorexant) is a dual orexin receptor antagonist, a newer class of sleep medication that blocks wake-promoting orexin signals in the brain. It is FDA-approved specifically for adults with insomnia who have trouble falling asleep, staying asleep, or both. It comes as a tablet taken once nightly, close to bedtime, at either 25 mg or 50 mg.

Trazodone vs. Quviviq Side Effects

Trazodone

Most common
Drowsiness (up to 41%)
Dry mouth (up to 34%)
Dizziness (up to 21%)
Headache (up to 10%)

Quviviq

Most common
Nasopharyngitis (up to 9.0%)
Headache (up to 6.5%)
Somnolence (5% to 7%)
Fatigue (5% to 7%)

Trazodone vs. Quviviq Dosage

Trazodone

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 25-50 mg at bedtime At the start
Maximum dose Up to 150 mg nightly If needed
Dose changes 2 increases As tolerated

Quviviq

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 25 mg once nightly At the start
Maximum dose 50 mg once nightly If needed
Dose changes 1 increase As tolerated

Trazodone vs. Quviviq Indications

Trazodone

Trazodone's only FDA-approved use is major depressive disorder in adults, with treatment starting at 150 mg per day in divided doses. Despite this, it is one of the most commonly prescribed medications for insomnia, used off-label at much lower bedtime doses. This off-label use is common in practice, but it has not been formally reviewed by the FDA for sleep specifically.

  • Major depressive disorder (FDA-approved)

  • Insomnia (off-label use only)

  • Sleep disturbance linked to depression or anxiety (off-label)

  • Sometimes used off-label as a non-habit-forming option for people with substance use history

Quviviq

Quviviq is FDA-approved for adults with insomnia, specifically for difficulty falling asleep, staying asleep, or both. It is not approved for narcolepsy or for use in children. As a Schedule IV controlled substance, it carries its own prescribing and monitoring requirements.

  • Difficulty falling asleep (FDA-approved)

  • Difficulty staying asleep (FDA-approved)

  • Adults only; not studied for pediatric insomnia

  • Not approved for narcolepsy

Trazodone vs. Quviviq Pros and Cons

Trazodone

Trazodone is a decades-old generic antidepressant with a long track record and low cost, but its use for sleep is off-label and not backed by the same FDA-reviewed dosing and safety data as a dedicated insomnia drug. It is not a controlled substance, which can simplify prescribing, but it carries antidepressant-specific warnings that don't apply to Quviviq.

Pros

  • Generic and typically costs $20 to $70 a month without insurance

  • Not a controlled substance, so it's easier to refill

  • Long clinical history across millions of patients since 1981

  • May help patients who have both depression and insomnia

Cons

  • Off-label for insomnia; the FDA has not reviewed it for that use

  • Carries a boxed warning for suicidal thoughts in young patients

  • Can cause next-day grogginess due to its longer half-life

  • Risk of priapism and orthostatic hypotension, especially in older adults

Quviviq

Quviviq carries an FDA-approved insomnia indication, its own dosing table, and clinical trial data specifically on sleep onset and maintenance, which trazodone's label does not have. It's a Schedule IV controlled substance, so prescribing and refills involve more regulatory oversight, and its list price is far higher than generic trazodone.

Pros

  • FDA-approved and studied specifically for insomnia

  • No evidence of physical dependence or withdrawal in trials

  • No dose adjustment needed for kidney problems

  • Newer mechanism (dual orexin blocker) targets sleep-wake signaling directly

Cons

  • Roughly $520 to $685 a month without insurance, before savings programs

  • Schedule IV controlled substance, with added prescribing restrictions

  • Not recommended for patients with severe liver impairment

  • Less real-world, long-term use history than older generic options

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.